Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
Blog Home
Jeff Margolin
Closed-End Fund Analyst
Click for Bio

Follow Jeff on LinkedIn
Ryan Issakainen
ETF Strategist
Click for Bio

Follow Ryan on LinkedIn

  Biotechnology Update
Posted Under: ETFs
Despite some volatility along the way, biotechnology stocks have significantly outperformed the S&P 500 Index over the past couple years, a trend that began in earnest after the surprise results of the 2016 elections. Since then (11/8/2016 – 1/31/2019), the First Trust NYSE Arca Biotechnology Index Fund (FBT) has posted a cumulative return of 60%, outperforming the S&P 500 Index by 28%. Below is an update to an article we wrote last year on some of the trends in the biotechnology industry that we believe may contribute to continued outperformance looking forward.

Click Here to continue reading.
Posted on Monday, February 25, 2019 @ 8:22 AM • Post Link Share: 
Print this post Printer Friendly

These posts were prepared by First Trust Advisors L.P., and reflect the current opinion of the authors. They are based upon sources and data believed to be accurate and reliable. Opinions and forward looking statements expressed are subject to change without notice. This information does not constitute a solicitation or an offer to buy or sell any security.
Consider the Less Expensive Defensive Trade
Alternatives Update 4th Quarter 2018
Fourth Quarter 2018 CEF Review
Did ETFs Cause the Q418 Sell-Off?
Senior Loan & High Yield Review - 4th Quarter 2018
Emerging Market Local Currency Review - 3rd Quarter 2018
GICS Sector Reshuffle Exacerbates Top-Heavy Concentration For Certain Sectors
U.S. Investment Grade Credit Investor Update - 3rd Quarter 2018
Alternatives Update 3rd Quarter 2018
Third Quarter 2018 CEF Review
Skip Navigation Links.
Search by Topic
Skip Navigation Links.

The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2020 All rights reserved.